Enzo Biochem, Inc.: $100m revs in F18. Pioneer in molecular diagnostics (Dx), leading convergence of clinical laboratories, life sciences and IP through devt of unique Dx platform technologies providing numerous advantages over previous standards.
Sector/industry:
Healthcare/Medical Diagnostics & Research
Characteristics:
Based in...
USA
Clinical Stage
Marketed
Disease Space
Diagnostics
Finance
Revenues
Industry
Biotechnology, Diagnostics
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Address:
527 Madison Avenue
New York, NY NY 10022
United States

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.